Rocket Pharmaceuticals completes $180 million priority review voucher sale
Go back to Rocket Pharmaceuticals completes $180 million priority review voucher sale| (NASDAQ: RCKT) | Delayed: 3.74 -0.12 (3.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.86 | 52 Week High | $ | |||
| Open | $3.78 | 52 Week Low | $ | |||
| Day High | $3.78 | P/E | N/A | |||
| Day Low | $3.68 | EPS | $ | |||
| Volume | 443,986 | |||||

